MIM Software Inc., a leading global provider of medical imaging software, is proud to support the efforts of the Melbourne Theronastic Innovation Centre (MTIC) in Melbourne, Victoria as they launch the use of the Siemens Biograph Vision Quadra PET/CT, one of the few such "all-organ" scanners in the world.

With the implementation of this new technology, the MTIC will strive to provide patient-specific precision medicine based on detailed disease characteristics using a combination of advanced molecular imaging tools and selective genomic analysis. In this regard, MIM Software is excited to serve as the backbone for the enterprise's diagnostic and therapeutic decision pathway. The partnership will also empower MTIC's long-term vision of accelerating translational research and innovation in clinical practice to meet the ever-changing needs of cancer diagnosis and therapy.

MTIC will be supported by MIM Encore^® and MIM SurePlan™ MRT at an enterprise level, facilitating AI-based tumor identification and segmentation using Contour ProtégéAI™ and voxel-based dosimetry for accurate analysis of the dosimetric impact throughout a patient's treatment regimen.

"We're proud to partner with MTIC to revolutionize cancer care. Our technology will enable earlier detection of high-risk cancers with a focus on personalized care," said Kanak Chatterjee, Vice President of International Business Development at MIM Software, Inc. "We're committed to supporting MTIC's mission to increase patient access to innovative solutions and improve their outcomes. I am confident that together with the indomitable team at MTIC, we will create game-changing approaches to meet the needs of cancer patients worldwide."

"With the 'all organ' dynamic imaging capability of the Siemens Biograph Vision Quadra PET/CT, there has never been a greater opportunity or need for tools to capture the rich data intrinsic in real-time molecular biological processes," said Rod Hicks, Founder, Executive Chairman, and Chief Medical Officer at MTIC." I can't imagine looking at these data without the powerful software provided by MIM and look forward to partnering with their fantastic team in further enhancing our ability to extract information that better informs patient care."